ORHub, Inc. (ORHB)
| Previous Close | 0.0309 |
| Open | 0.0344 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0290 - 0.0344 |
| 52 Week Range | 0.0223 - 0.1000 |
| Volume | |
| Avg. Volume | 157,951 |
| Market Cap | 5.261M |
| Beta (5Y Monthly) | -0.30 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE
Hippofi Welcomes Scott Bauccio as New Head of Sales for Pur Biologics
IRVINE, CA / ACCESSWIRE / January 23, 2024 / HippoFi's (OTC PINK:ORHB) biotechnology business PUR Biologics, proudly announces Scott Bauccio as its new Head of Sales. Utilizing his 20 years of sales management and his extensive network of industry- ...
- ACCESSWIRE
HippoFi Ships International Orders and Expects Sales to Exceed $20 Million in the New Year
HippoFi's wholly owned subsidiary, PUR Biologics breaks into the international market.IRVINE, CA / ACCESSWIRE / December 11, 2023 / HippoFi's (OTC PINK:ORHB) biotechnology business PUR Biologics, began selling and shipping products for international ...
- ACCESSWIRE
HippoFi Continues to Deliver Sales Growth Adding 14 Major Healthcare Facilities
Expanding our reach in 2024, HippoFi and PUR Biologics are setting new standards in innovative spine care solutions.IRVINE, CA / ACCESSWIRE / December 5, 2023 / (OTC PINK:ORHB) HippoFi's wholly owned subsidiary, PUR Biologics, is advancing its distribution ...
